Literature DB >> 15302461

Steroid hormones and hormone-related genetic and lifestyle characteristics as risk factors for benign prostatic hyperplasia: review of epidemiologic literature.

Marian L Neuhouser1, Alan R Kristal, David F Penson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302461     DOI: 10.1016/j.urology.2004.04.025

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  4 in total

Review 1.  Risk factors for benign prostatic hyperplasia.

Authors:  Steven J Jacobsen
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

2.  Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium.

Authors:  Jay H Fowke; Dale F McLerran; Prakash C Gupta; Jiang He; Xiao-Ou Shu; Kunnambath Ramadas; Shoichiro Tsugane; Manami Inoue; Akiko Tamakoshi; Woon-Puay Koh; Yoshikazu Nishino; Ichiro Tsuji; Kotaro Ozasa; Jian-Min Yuan; Hideo Tanaka; Yoon-Ok Ahn; Chien-Jen Chen; Yumi Sugawara; Keun-Young Yoo; Habibul Ahsan; Wen-Harn Pan; Mangesh Pednekar; Dongfeng Gu; Yong-Bing Xiang; Catherine Sauvaget; Norie Sawada; Renwei Wang; Masako Kakizaki; Yasutake Tomata; Waka Ohishi; Lesley M Butler; Isao Oze; Dong-Hyun Kim; San-Lin You; Sue K Park; Faruque Parvez; Shao-Yuan Chuang; Yu Chen; Jung Eun Lee; Eric Grant; Betsy Rolland; Mark Thornquist; Ziding Feng; Wei Zheng; Paolo Boffetta; Rashmi Sinha; Daehee Kang; John D Potter
Journal:  Am J Epidemiol       Date:  2015-08-04       Impact factor: 4.897

3.  Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms.

Authors:  Nassim Aourag; Johan F Langenhuijsen; Frank d'Ancona; John Heesakkers
Journal:  Cent European J Urol       Date:  2019-03-12

4.  Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk.

Authors:  Weiqiang Li; Robert J Klein
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-11-20       Impact factor: 5.554

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.